CD200R1 and arthritic joint disease: These CD200+ fibroblasts have the capacity to dampen inflammatory pathways, as identified with gene‐set enrichment analysis, and facilitate arthritis resolution via CD200‐CD200R1 signaling on type 2 innate lymphoid cells [35].